DrugDashboards

Paroxetine

Paroxetine · PAROXETINE HYDROCHLORIDE HEMIHYDRATE 37.5 mg/1 · Tablet, Film Coated, Extended Release · Oral · Lupin Pharmaceuticals, Inc.

NDC 68180-0645-06 · 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE · ANDA · View full market →

The short version

7 companies supply this market — a reasonable cushion if one runs into trouble. The price has held steady around $0.4657 per unit over the past year. One of its named manufacturing plants, Lupin Limited, failed FDA inspectionwithin the last two years — the agency’s most serious outcome. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.4657per EAinvoice-surveyed acquisition cost · Jul 23, 2025
  • Medicaid generic ceiling (FUL)$0.5530per TABweighted avg manufacturer price $0.2189 · Sep 1, 2025119% of what pharmacies pay — higher than 67% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$2.00$4.00$6.00Mar 2017Jul 2025$0.4657
102 price points · per EA · last surveyed Invalid Date · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

#30 count
$13.97
#90 count
$41.91

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Medicaid spend (2024)

$11,192
374 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

0Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for paroxetine (oral solid) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA204134
TE code
Approval date
Jan 20, 2017
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class III · TerminatedJun 22, 2017
    Lupin Pharmaceuticals Inc.Failed Dissolution Specifications: out of specification observed in dissolution testing at 3 month long term stability study.

Manufacturers of Paroxetine (Tablet, Film Coated, Extended Release)

LabelerStrengthFirst seenLast seen
Alembic Pharmaceuticals Inc.PAROXETINE HYDROCHLORIDE HEMIHYDRATE 12.5 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.PAROXETINE HYDROCHLORIDE HEMIHYDRATE 37.5 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.PAROXETINE HYDROCHLORIDE HEMIHYDRATE 25 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedPAROXETINE HYDROCHLORIDE HEMIHYDRATE 37.5 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedPAROXETINE HYDROCHLORIDE HEMIHYDRATE 12.5 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedPAROXETINE HYDROCHLORIDE HEMIHYDRATE 25 mg/1Jul 15, 2026Sep 2, 2026
Cadila Pharmaceuticals LimitedPAROXETINE HYDROCHLORIDE HEMIHYDRATE 25 mg/1Jul 15, 2026Sep 2, 2026
Cadila Pharmaceuticals LimitedPAROXETINE HYDROCHLORIDE HEMIHYDRATE 12.5 mg/1Jul 15, 2026Sep 2, 2026
Cadila Pharmaceuticals LimitedPAROXETINE HYDROCHLORIDE HEMIHYDRATE 37.5 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCPAROXETINE HYDROCHLORIDE 37.5 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCPAROXETINE HYDROCHLORIDE 25 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCPAROXETINE HYDROCHLORIDE 12.5 mg/1Jul 15, 2026Sep 2, 2026
Lupin Pharmaceuticals, Inc.PAROXETINE HYDROCHLORIDE HEMIHYDRATE 37.5 mg/1Jul 15, 2026Sep 2, 2026
Lupin Pharmaceuticals, Inc.PAROXETINE HYDROCHLORIDE HEMIHYDRATE 25 mg/1Jul 15, 2026Sep 2, 2026
Modavar Pharmaceuticals LLCPAROXETINE HYDROCHLORIDE HEMIHYDRATE 25 mg/1Jul 15, 2026Sep 2, 2026
Modavar Pharmaceuticals LLCPAROXETINE HYDROCHLORIDE HEMIHYDRATE 12.5 mg/1Jul 15, 2026Sep 2, 2026
Modavar Pharmaceuticals LLCPAROXETINE HYDROCHLORIDE HEMIHYDRATE 37.5 mg/1Jul 15, 2026Sep 2, 2026
Westminster Pharmaceuticals, LLCPAROXETINE HYDROCHLORIDE 37.5 mg/1Jul 15, 2026Sep 2, 2026
Westminster Pharmaceuticals, LLCPAROXETINE HYDROCHLORIDE 12.5 mg/1Jul 15, 2026Sep 2, 2026
Westminster Pharmaceuticals, LLCPAROXETINE HYDROCHLORIDE 25 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Paroxetine — NDC 68180-0645-06," retrieved September 3, 2026, https://drugdashboards.com/drug/68180064506.

Free to cite with attribution — see how the data is put together.